These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 6259785)

  • 1. Aflatoxin B1 in hepatocellular carcinoma.
    Onyemelukwe CG; Nirodi C; West CE
    Trop Geogr Med; 1980 Sep; 32(3):237-40. PubMed ID: 6259785
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aflatoxin B1 DNA adducts in smeared tumor tissue from patients with hepatocellular carcinoma.
    Chen CJ; Zhang YJ; Lu SN; Santella RM
    Hepatology; 1992 Nov; 16(5):1150-5. PubMed ID: 1385290
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alpha-fetoprotein as a tumor marker in hepatocellular carcinoma: investigations in south Indian subjects with hepatotropic virus and aflatoxin etiologies.
    Murugavel KG; Mathews S; Jayanthi V; Shankar EM; Hari R; Surendran R; Vengatesan A; Raghuram K; Rajasambandam P; Murali A; Srinivas U; Palaniswamy KR; Pugazhendhi T; Thyagarajan SP
    Int J Infect Dis; 2008 Nov; 12(6):e71-6. PubMed ID: 18658001
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aflatoxins as a risk factor for hepatocellular carcinoma in Egypt, Mansoura Gastroenterology Center study.
    Abdel-Wahab M; Mostafa M; Sabry M; el-Farrash M; Yousef T
    Hepatogastroenterology; 2008; 55(86-87):1754-9. PubMed ID: 19102385
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Common clinicopathological features of the patients with chronic hepatitis B virus infection who developed hepatocellular carcinoma after seroconversion to anti-HBs--a consideration of the pathogenesis of HBV-induced hepatocellular carcinoma and a strategy to inhibit it.
    Tsuboi Y; Ohkoshi S; Yano M; Suzuki K; Tsubata SS; Ishihara K; Ichida T; Sugitani S; Shibazaki K; Aoyagi Y
    Hepatogastroenterology; 2006; 53(67):110-4. PubMed ID: 16506387
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis B virus, hepatocellular carcinoma and liver cirrhosis in Kenya.
    Mwangi J; Gatei DG
    East Afr Med J; 1993 Apr; 70(4 Suppl):34-6. PubMed ID: 8223308
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aflatoxin, viral hepatitis and primary liver cancer.
    Stora C; Dvorackova I
    J Med; 1987; 18(1):23-41. PubMed ID: 3036991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dominant role of hepatitis B virus and cofactor role of aflatoxin in hepatocarcinogenesis in Qidong, China.
    Ming L; Thorgeirsson SS; Gail MH; Lu P; Harris CC; Wang N; Shao Y; Wu Z; Liu G; Wang X; Sun Z
    Hepatology; 2002 Nov; 36(5):1214-20. PubMed ID: 12395332
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HBsAg, aflatoxins and primary hepatocellular carcinoma.
    Olubuyide IO; Maxwell SM; Hood H; Neal GE; Hendrickse RG
    Afr J Med Med Sci; 1993 Sep; 22(3):89-91. PubMed ID: 7839921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative analysis of HBV and HCV infection in hepatocellular carcinoma and chronic liver disease--an autopsy based study.
    Vaiphei K; Pal NS; Arora SK
    Indian J Pathol Microbiol; 2006 Jul; 49(3):357-61. PubMed ID: 17001884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HBsAg-negative hepatitis B virus infections in hepatitis C virus-associated hepatocellular carcinoma.
    Momosaki S; Nakashima Y; Kojiro M; Tabor E
    J Viral Hepat; 2005 May; 12(3):325-9. PubMed ID: 15850475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatic siderosis, fibrosis and cirrhosis: the association with hepatocellular carcinoma in high-risk population.
    Jaskiewicz K; Banach L; Lancaster E
    Anticancer Res; 1997; 17(5B):3897-9. PubMed ID: 9427800
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aflatoxins in liver biopsies from Kenya.
    De Vries HR; Lamplugh SM
    Trop Geogr Med; 1989 Jan; 41(1):26-30. PubMed ID: 2548310
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liver cell dysplasia in liver cirrhosis and hepatocellular carcinoma.
    Szczepański W
    Pol J Pathol; 1997; 48(3):147-57. PubMed ID: 9401407
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TP53 R249S mutations, exposure to aflatoxin, and occurrence of hepatocellular carcinoma in a cohort of chronic hepatitis B virus carriers from Qidong, China.
    Szymañska K; Chen JG; Cui Y; Gong YY; Turner PC; Villar S; Wild CP; Parkin DM; Hainaut P
    Cancer Epidemiol Biomarkers Prev; 2009 May; 18(5):1638-43. PubMed ID: 19366907
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blood aflatoxin levels in patients with hepatocellular carcinoma in Singapore.
    Tan CK; Lo DS; Law NM; Ng HS; Chao TC
    Singapore Med J; 1995 Dec; 36(6):612-4. PubMed ID: 8781632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A 28-year study of the course of hepatitis Delta infection: a risk factor for cirrhosis and hepatocellular carcinoma.
    Romeo R; Del Ninno E; Rumi M; Russo A; Sangiovanni A; de Franchis R; Ronchi G; Colombo M
    Gastroenterology; 2009 May; 136(5):1629-38. PubMed ID: 19208358
    [TBL] [Abstract][Full Text] [Related]  

  • 18. P53 codon 249 mutation in hepatocellular carcinomas from Nigeria.
    Ndububa DA; Yakicier CM; Ojo OS; Adeodu OO; Rotimi O; Ogunbiyi O; Ozturk M
    Afr J Med Med Sci; 2001; 30(1-2):125-7. PubMed ID: 14510167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cigarette smoking, alcohol drinking, hepatitis B, and risk for hepatocellular carcinoma in Korea.
    Jee SH; Ohrr H; Sull JW; Samet JM
    J Natl Cancer Inst; 2004 Dec; 96(24):1851-6. PubMed ID: 15601641
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical features of HBsAg-negative but anti-HBc-positive hepatocellular carcinoma in a hepatitis B virus endemic area.
    Shim J; Kim BH; Kim NH; Dong SH; Kim HJ; Chang YW; Lee JI; Chang R
    J Gastroenterol Hepatol; 2005 May; 20(5):746-51. PubMed ID: 15853989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.